Dear Doctor - Participate in the Survey on hypothyroidism "A new survey has found that nearly one in four Americans adults have hypothyroidism, a condition in which the body produces too little thyroid hormone. This means that more than 20 million people in the United States alone are living with hypothyroidism.The findings, published in the journal JAMA Network Open, come from a nationally representative survey of nearly 4,000 adults. Participants were asked whether they had ever been told by a doctor or other health care professional that they had hypothyroidism.Overall, the prevalence of hypothyroidism was 24.5%, with women (28%) nearly twice as likely as men (16%) to have the condition. The prevalence also increased with age, from 5% among adults aged 18-34 to 39% among those aged 65 and older.There are a number of possible explanations for these findings. For one, the thyroid gland itself may become less efficient with age. Additionally, preconception and pregnancy can both lead to changes in thyroid function that can result in hypothyroidism. Given the high prevalence of both of these conditions among women, it's not surprising that they would be more likely to develop hypothyroidism.The good news is that hypothyroidism is highly treatable with medication. If you think you may have hypothyroidism, talk to your doctor about getting tested. Participate now"
1.
Colon cancer and exercise: Can physical activity reprogram genes?
2.
For relapsed or resistant DLBCL, odronextamab produced positive results.
3.
Improved end-of-life conversations for cancer patients are identified by a new study.
4.
Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer
5.
Xerostomia in Head and Neck Cancer Patients Can Be Predicted by Mid-Treatment PET/CT Scans.
1.
Treating Methemoglobinemia: What You Need to Know Now!
2.
Is AI The New Radiologist For Breast MRI?
3.
Advancements in Squamous Cell Carcinoma Treatment: Decoding Survival Strategies and Molecular Pathways to Improve Cure Rates
4.
Unlocking the Potential of Pirtobrutinib: A New Frontier in Cancer Treatment
5.
Unleashing the Oncolytic Arsenal: Talimogene Laherparepvec Monotherapy – A Targeted Cancer Immunotherapy Treatment
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
2.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
4.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
5.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation